|
CCDC82 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32036612146658E-13 |
| Normal-vs-Stage2 |
2.12069994898201E-09 |
| Normal-vs-Stage3 |
3.13304937549219E-12 |
| Normal-vs-Stage4 |
1.64290803184031E-12 |
| Stage1-vs-Stage2 |
2.745200E-01 |
| Stage1-vs-Stage3 |
1.348800E-01 |
| Stage1-vs-Stage4 |
5.457000E-03 |
| Stage2-vs-Stage3 |
9.813800E-01 |
| Stage2-vs-Stage4 |
2.012800E-01 |
| Stage3-vs-Stage4 |
1.263830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.99760216648792E-15 |
| Normal-vs-AfricanAmerican |
3.37900000002556E-06 |
| Normal-vs-Asian |
1.30909999951356E-07 |
| Caucasian-vs-AfricanAmerican |
9.003400E-01 |
| Caucasian-vs-Asian |
3.317400E-01 |
| AfricanAmerican-vs-Asian |
6.074200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87627691161651E-14 |
| Normal-vs-Female |
1.64035451888367E-12 |
| Male-vs-Female |
5.807200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.01303426653021E-12 |
| Normal-vs-Age(41-60Yrs) |
1.6991963391888E-11 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
8.08900000000001E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.348400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.643300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.740200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.431900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.579200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.835000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.832200E-04 |
| Classical-VS-Follicular |
5.124000E-03 |
| Classical-VS-Other |
6.057600E-01 |
| Classical-VS-Normal |
9.28690457868697E-12 |
| Tall-VS-Follicular |
2.396200E-01 |
| Tall-VS-Other |
2.471400E-01 |
| Tall-VS-Normal |
5.43454170554014E-13 |
| Follicular-VS-Other |
6.823800E-01 |
| Follicular-VS-Normal |
2.04303240991521E-12 |
| Other-VS-Normal |
2.643900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48769885299771E-14 |
| Normal-vs-N1 |
2.00439997932733E-09 |
| N0-vs-N1 |
6.574800E-01 |
|
|
